-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

322. Disorders of Coagulation or Fibrinolysis: Clinical and Epidemiological: Poster II

Program: Oral and Poster Abstracts
Type: Poster
Sunday, December 12, 2021: 6:00 PM-8:00 PM
Hall B5, Level 1, Building B (Georgia World Congress Center)

Tina Manon-Jensen, PhD1*, Srilatha Tangada2, Cecilie Bager3*, Pratima Chowdary4*, Robert Klamroth5*, Annette von Drygalski, MD, Pharm D6, Jerzy Windyga, MD, PhD7*, Miguel A. Escobar, MD8*, Peder Frederiksen3*, Werner Engl9*, Bruce Ewenstein10 and Morten Karsdal11*

1Nordic Bioscience, Herlev, DNK
2Takeda Development Center Americas, Inc., Cambridge, MA
3Nordic Bioscience, Herlev, Denmark
4KD Haemophilia and Thrombosis Centre, Royal Free Hospital, London, United Kingdom
5Department for Internal Medicine, Vascular Medicine and Haemostaseology, Vivantes Klinikum im Friedrichshain, Berlin, Berlin, Germany
6Department of Medicine, Division of Hematology/Oncology, University of California San Diego, San Diego, CA
7Department of Hemostasis Disorders and Internal Medicine, Institute of Hematology and Transfusion Medicine, Warsaw, Poland
8Department of Hematology, University of Texas Health Science Center, Houston, TX
9Baxter Innovations Gmbh, Vienna, AUT
10Baxalta US Inc., a Takeda company, Cambridge, MA
11Nordic Biosciences, Herlev, Denmark

Víctor Jiménez-Yuste1*, Johannes Oldenburg2, Eunice Tzeng3*, Ben Trzaskoma3*, Fabian Sanabria4* and Johnny Mahlangu, BSc, MB BCh, MMed, FCPath5

1Hospital Universitario La Paz, Autónoma University, Madrid, Spain
2Institute for Experimental Hematology and Transfusion Medicine, Bonn University Clinic, Bonn, Germany
3Genentech, Inc., South San Francisco, CA
4F. Hoffmann-La Roche Ltd, Basel, Switzerland
5University of the Witwatersrand and National Health Laboratory Service, Johannesburg, South Africa

Yi Wang1*, Gülden Özen1, Björn Mellgård1, Jean Francois Marier2*, Olivier Barriere2*, Grygoriy Vasilinin2* and Indranil Bhattacharya1*

1Takeda Development Center Americas, Inc., Cambridge, MA
2Certara Strategic Consulting, Princeton, NJ

Tyler W. Buckner1, Shannon L Carpenter, MD2, Nabil Daoud3*, Nikki Hirsh4*, Thomas W. McLean5*, Carrie O'Neill4*, Leslie J. Raffini, MD6, Ayesha Zia, MD, MSc7 and Michael Recht3,8

1Divisions of Hematology and Pediatric Hematology/Oncology, Hemophilia and Thrombosis Center, University of Colorado School of Medicine, Aurora, CO
2Children's Mercy Hospital, Kansas City, MO
3American Thrombosis and Hemostasis Network, Rochester, NY
4American Thrombosis And Hemostasis Network, Rochester, NY
5Wake Forest University School of Medicine, Winston Salem, NC
6Division of Hematology, The Children's Hospital of Philadelphia, Philadelphia, PA
7University of Texas Southwestern Medical Center, Dallas, TX
8The Hemophilia Center, Oregon Health & Science University, Portland, OR

Susan Halimeh, MD1, Hannelore Rott, PhD2*, Günther Kappert3*, Manuela Siebert4* and Dirk Reinhardt, MD5

1Universitätsklinikum Essen,, Essen, Germany
2Gerinnungszentrum rhein ruhr, Duisburg, DEU
3Gerinnungszentrum rhein ruhr, Duisburg, Germany
4Gerinnungszentrum rhein ruhr, Duisurg, DEU
5Department of Pediatric Hematology and Oncology, Essen University Hospital, Essen, Germany

Michelle Witkop1*, Tao Xu2*, Gillian Hanson3*, Richard Ofori-Asenso4*, Richard H. Ko, MD, MHS, MS5, Emily Cibelli, PhD3*, Martynas Aizenas2*, Mark W Skinner6*, Fabian Sanabria2* and Amy D. Shapiro7

1National Hemophilia Foundation, New York, NY
2F. Hoffmann-La Roche Ltd, Basel, Switzerland
3PicnicHealth, San Francisco, CA
4Roche Products Ltd, Welwyn Garden City, United Kingdom
5Genentech, Inc., South San Francisco, CA
6McMaster University, Hamilton, ON, Canada
7Indiana Hemophilia and Thrombosis Center, Indianapolis, IN

Lei Meng1*, Jiaxin Lv2*, Bin Chen2*, Qiang Li3*, Zhuqin Liu4*, Guiyong Jiang2*, Yufang Xun5*, Fei Liu2*, Keyu Chen2*, Qifa Liu1 and Jing Sun, MD1

1Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China
2Nanfang Hospital, Southern Medical University, Guangzhou, China
3Department of Laboratory Medicine, Nanfang Hospital, Southern Medical University, Guangzhou, China
4Department of Hematology,Nanfang Hospital,Southern Medical University, Guangzhou, China
5Nanfang Hospital, Guangzhou, HI, China

Christian Pfrepper, MD1*, Paolo Radossi2*, Jerzy Windyga3*, Kaan Kavakli, MD, PhD4*, Roger E.G. Schutgens5*, Nazan Sarper, MD6*, Jovanna Baptista7*, Kayode Badejo, MD7*, Bruce Ewenstein7 and Nisha Jain7

1Division of Hemostaseology, Department of Hematology, Cellular Therapy and Hemostaseology, University Hospital Leipzig, Leipzig, Germany
2Oncohematology Department Istituto Oncologico Veneto, Castelfranco Veneto Hospital, Castelfranco Veneto, Italy
3Department of Hemostasis Disorders and Internal Medicine, Institute of Hematology and Transfusion Medicine, Warsaw, Poland
4Department of Hematology, Ege University Faculty of Medicine, Children's Hospital, Izmir, Turkey
5Van Creveldkliniek, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands
6Kocaeli University Medical Faculty, Kocaeli, Turkey
7Takeda Development Center Americas, Inc., Cambridge, MA

Azusa Nagao1*, Akiko Ioka2*, Takao Nakamura2*, Yoichi Murakami2*, Misako Makishima2*, Norihiro Okada2* and Michio Sakai3*

1Ogikubo Hospital, Tokyo, Japan
2Chugai Pharmaceutical, Co., Ltd., Tokyo, Japan
3Munakata Suikokai General Hospital, Fukuoka, Japan

Kelly Bajorek, BS1*, Matthew Martin, BA, BS, MS2*, Joseph S. Palumbo, MD2,3, Cristina Tarango, MD2,3, Eric S. Mullins, MD4 and Lori Luchtman-Jones, MD5,6

1University of Cincinnati College of Medicine, Cincinnati, OH
2Cancer and Blood Diseases Institute, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH
3Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH
4University of Cincinnati - College of Medicine, Cincinnati, OH
5Division of Hematology, Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, OH
6Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH

Randall Curtis, MBA1*, Jonathan C. Roberts, MD2, Nicole Crook, RN3*, Marquita Decker-Palmer, MD, PhD4*, Rahul Khairnar, PhD5*, Judith Baker, DrPH, MHSA6*, Megan M. Ullman, MA, MPH7*, Marion A. Koerper, MD8, Joanne Wu, MD, MS9* and Michael B. Nichol, PhD10*

1Factor VIII Computing, Berkeley, CA
2Bleeding & Clotting Disorders Institute, Peoria, IL
3The Center for Comprehensive Care & Diagnosis of Inherited Blood Disorders, Orange, CA
4Genentech Inc., South San Francisco, CA
5Genentech, Inc., South San Francisco, CA
6The Center For Comprehensive Care & Diagnosis of Inherited Blood Disorders, Orange, CA
7Gulf States Hemophilia & Thrombophilia Center and University of Texas Health Science Center at Houston, Houston, TX
8University of California San Francisco, San Francisco, CA
9University Of Southern California, Los Angeles, CA
10University of Southern California, Los Angeles, CA

Zhuo-Yu An1*, Ye-Jun Wu1*, Yun He1*, Xiao-Lu Zhu1*, Yan Su1*, Chen-Cong Wang1*, Tian-Xiao Han1*, Hai-Xia Fu1*, Feng-Rong Wang1*, Xiao-Dong Mo1*, Yu Wang1*, Xiang-Yu Zhao1*, Yuan-Yuan Zhang1*, Wei Han1*, Huan Chen1*, Yao Chen2*, Chen-Hua Yan1*, Jing-Zhi Wang1*, Ting-Ting Han1*, Yu-Hong Chen1*, Yi-Fei Cheng1*, Ying-Jun Chang1, Lan-Ping Xu3*, Kai-Yan Liu1, Xiao Jun Huang, MD4 and Xiaohui Zhang1*

1Peking University People’s Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Collaborative Innovation Center of Hematology, Beijing, China
2Peking University People’s Hospital, Peking University Institute of Hematology, Beijing, China
3Peking University People’s Hospital, Beijing, China
4Peking University People's Hospital, Beijing, China

Kenichi Ogiwara, MD, PhD1*, Shoko Furukawa, MD, PhD1*, Kana Sasai1*, Keito Inaba2*, Takehisa Kitazawa, DVM2* and Keiji Nogami, MD, PhD1*

1Department of Pediatrics, Nara Medical University, Kashihara, Japan
2Research Division, Chugai Pharmaceutical Co., Ltd., Gotemba, Japan

Guy Young, MD1, Mark T Reding, MD2, Robert F. Sidonio Jr., MD, MSc3, Doris V. Quon4, Janice M. Staber5, Cindy A. Leissinger, MD6, Jessica Charlet, PhD, MSc, BSc7* and Moncef Boukerrou7*

1Children's Hospital Los Angeles, University of Southern California Keck School of Medicine, Los Angeles, CA
2Center for Bleeding and Clotting Disorders, University of Minnesota Medical Center, Minneapolis, MN
3Emory University, Atlanta, GA
4Los Angeles Orthopedic Hemophilia Treatment Center, Orthopedic Institute for Children, Los Angeles, CA
5University of Iowa Stead Family Children’s Hospital, Iowa City, IA
6Tulane University, New Orleans, LA
7Bayer, Whippany

Ampaiwan Chuansumrit, MD1*, Nongnuch Sirachainan, MD.1*, Suphaneewan Jaovisidha, MD.2*, Tachit Jiravichitchai, MD.3*, Praguywan Kadegasem, BSc.1*, Ketsuda Kempka, MSc.4*, Monratta Panuwannakorn, MD.3*, Wannaphorn Rotchanapanya, MD5* and Thunyakorn Nuntiyakul, MD.6*

1Mahidol University, Department of Pediatrics, Faculty of Medicine Ramathibodi Hospital, Bangkok, Thailand
2Department of Radiology, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand
3Department of Rehabilitation, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand
4Department of Nursing, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand
5Chiang Rai Regional Hospital, Chiang Rai, Thailand
6Chaophrayayommarat Hospital, Suphaburi Province, Suphaburi, Thailand

*signifies non-member of ASH